← All trials
NCT06445465
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 24, 2020
- Primary completion
- Jul 31, 2024
- Completion date
- Aug 31, 2024
- First posted
- Jun 6, 2024
- Last posted
- Jun 6, 2024
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- InvicroLead sponsor
- AC Immune SACollaborator
- InvicroOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.